Wednesday, September 18, 2024 9:10:54 AM
Where does it go today.
Recent VVOS News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/11/2026 04:15:14 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/08/2026 09:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 08:25:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 09:15:08 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 09:00:25 PM
- Vivos Therapeutics Reports Full Year 2025 Financial Results • GlobeNewswire Inc. • 04/15/2026 08:20:00 PM
- Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call • GlobeNewswire Inc. • 04/15/2026 12:45:00 PM
- Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners • GlobeNewswire Inc. • 04/07/2026 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:34:11 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 04/02/2026 10:32:59 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 08:01:29 PM
- Vivos Therapeutics secures Nevada insurer access and implements cost cuts • IH Market News • 03/26/2026 02:00:55 PM
- Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market • GlobeNewswire Inc. • 03/26/2026 12:45:00 PM
- Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy • GlobeNewswire Inc. • 03/17/2026 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:05:34 PM
- Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies • GlobeNewswire Inc. • 02/05/2026 01:45:00 PM
- Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds • GlobeNewswire Inc. • 01/20/2026 10:31:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 09:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 09:05:42 PM
- Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds • GlobeNewswire Inc. • 01/16/2026 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/14/2026 09:05:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/02/2026 09:44:43 PM
